Impact of histone deacetylase 1 and metastasis-associated gene 1 expression in esophageal carcinogenesis

Oncology Letters

Volumn 8, Issue 2, 2014, Pages 758-764

  Miyashita, Tomoharu ^a   Tajima, Hidehiro ^a   Munemoto, Masayoshi ^a   Shah, Furhawn A ^b   Harmon, John W ^b   Watanabe, Toshifumi ^a   Shoji, Masatoshi ^a   Okamoto, Koichi ^a   Nakanuma, Shinichi ^a   Sakai, Seisho ^a   Kinoshita, Jun ^a   Makino, Isamu ^a   Nakamura, Keishi ^a   Hayashi, Hironori ^a   Oyama, Katsunobu ^a   Inokuchi, Masafumi ^a   Nakagawara, Hisatoshi ^a   Takamura, Hiroyuki ^a   Ninomiya, Itasu ^a   Kitagawa, Hirohisa ^a   Fushida, Sachio ^a   Mukaisho, Kenichi ^c   Fujimura, Takashi ^a   Ohta, Tetsuo ^a   more..

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Barrett's esophagus; Esophageal adenocarcinoma; Esophageal carcinogenesis; Histone deacetylases; Metastasis associated gene

Indexed keywords

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARRETTS METAPLASIA; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ESOPHAGOJEJUNOSTOMY; ESOPHAGUS CARCINOMA; GASTRECTOMY; GENE; GENE EXPRESSION; HISTOLOGY; HISTONE DEACETYLASE 1 GENE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; METAPLASIA; METASTASIS ASSOCIATED GENE 1; NONHUMAN; PROLIFERATIVE SQUAMOUS HYPERPLASIA; RAT; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE;

EID: 84902315517     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2176     Document Type: Article

References (43)

1. Hongo M, Nagasaki Y and Shoji T: Epidemiology of esophageal cancer: Orient to occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 24: 729-735, 2009.
2. Wheeler JB and Reed CE: Epidemiology of esophageal cancer. Surg Clin North Am 92: 1077-1087, 2012.
3. Bollschweiler E, Wolfgarten E, Gutschow C and Hölscher AH: Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 92: 549-555, 2001.
4. Reid BJ, Li X, Galipeau PC and Vaughan TL: Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer 10: 87-101, 2010.
5. Engel LS, Chow WH, Vaughan TL, et al: Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 95: 1404-1413, 2003.
6. Lagergren J, Bergström R, Lindgren A and Nyrén O: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340: 825-831, 1999.
7. Jankowski JA, Harrison RF, Perry I, Balkwill F and Tselepis C: Barrett's metaplasia. Lancet 356: 2079-2085, 2000.
8. Miwa K, Segawa M, Takano Y, et al: Induction of oesophageal and forestomach carcinomas in rats by reflux of duodenal contents. Br J Cancer 70: 185-189, 1994.
9. Miwa K, Sahara H, Segawa M, et al: Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 67: 269-274, 1996.
10. Miyashita T, Ohta T, Fujimura T, et al: Duodenal juice stimulates oesophageal stem cells to induce Barrett's oesophagus and oesophageal adenocarcinoma in rats. Oncol Rep 15: 1469-1475, 2006.
11. Miyashita T, Miwa K, Fujimura T, et al: The severity of duodeno-esophageal reflux influences the development of different histological types of esophageal cancer in a rat model. Int J Cancer 132: 1496-1504, 2013.
12. Bonde P, Sui G, Dhara S, et al: Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model. J Thorac Cardiovasc Surg 133: 763-769, 2007.
13. Nawa A, Nishimori K, Lin P, et al: Tumor metastasis-associated human MTA1 gene: its deduced protein sequence, localization, and association with breast cancer cell proliferation using antisense phosphorothioate oligonucleotides. J Cell Biochem 79: 202-212, 2000.
14. Toh Y, Ohga T, Endo K, et al: Expression of the metastasis-associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas. Int J Cancer 110: 362-367, 2004.
15. Toh Y, Pencil SD and Nicolson GL: Analysis of the complete sequence of the novel metastasis-associated candidate gene, mta1, differentially expressed in mammary adenocarcinoma and breast cancer cell lines. Gene 159: 97-104, 1995.
16. Iguchi H, Imura G, Toh Y and Ogata Y: Expression of MTA1, a metastasis-associated gene with histone deacetylase activity in pancreatic cancer. Int J Oncol 16: 1211-1214, 2000.
17. Higashijima J, Kurita N, Miyatani T, et al: Expression of histone deacetylase 1 and metastasis-associated protein 1 as prognostic factors in colon cancer. Oncol Rep 26: 343-348, 2011.
18. Nicolson GL, Nawa A, Toh Y, Taniguchi S, Nishimori K and Moustafa A: Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation. Clin Exp Metastasis 20: 19-24, 2003.
19. Moon WS, Chang K and Tarnawski AS: Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: Relationship to vascular invasion and estrogen receptor-alpha. Hum Pathol 35: 424-429, 2004.
20. Kai L, Samuel SK and Levenson AS: Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex. Int J Cancer 126: 1538-1548, 2010.
21. Toh Y, Yamamoto M, Endo K, et al: Histone H4 acetylation and histone deacetylase 1 expression in esophageal squamous cell carcinoma. Oncol Rep 10: 333-338, 2003.
22. Sun WJ, Zhou X, Zheng JH, et al: Histone acetyltransferases and deacetylases: molecular and clinical implications to gastrointestinal carcinogenesis. Acta Biochim Biophys Sin (Shanghai) 44: 80-91, 2012.
23. Toh Y and Nicolson G: MTA1 of the MTA (metastasis-associated) gene family and its encoded proteins: molecular and regulatory functions and role in human cancer progression. Atlas Genet Cytogenet Oncol Haematol 15: 303-315, 2011.
24. Moon HE, Cheon H and Lee MS: Metastasis-associated protein 1 inhibits p53-induced apoptosis. Oncol Rep 18: 1311-1314, 2007.
25. Abdel-Latif MM, Duggan S, Reynolds JV and Kelleher D: Inflammation and esophageal carcinogenesis. Curr Opin Pharmacol 9: 396-404, 2009.
26. Ramsey MR, He L, Forster N, Ory B and Ellisen LW: Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional repression and tumor maintenance in squamous cell carcinoma. Cancer Res 71: 4373-4379, 2011.
27. Langer R, Mutze K, Becker K, et al: Expression of class I histone deacetylases (HDAC1 and HDAC2) in oesophageal adenocarcinomas: an immunohistochemical study. J Clin Pathol 63: 994-998, 2010.
28. Toh Y, Kuwano H, Mori M, Nicolson GL and Sugimachi K: Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas. Br J Cancer 79: 1723-1726, 1999.
29. Tong JK, Hassig CA, Schnitzler GR, Kingston RE and Schreiber SL: Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature 395: 917-921, 1998.
30. Xue Y, Wong J, Moreno GT, Young MK, Côté J and Wang W: NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell 2: 851-861, 1998.
31. Wade PA, Gegonne A, Jones PL, Ballestar E, Aubry F and Wolffe AP: Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat Genet 23: 62-66, 1999.
32. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A and Reinberg D: Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 13: 1924-1935, 1999.
33. Bowen NJ, Fujita N, Kajita M and Wade PA: Mi-2/NuRD: multiple complexes for many purposes. Biochim Biophys Acta 1677: 52-57, 2004.
34. Toh Y, Kuninaka S, Endo K, et al: Molecular analysis of a candidate metastasis-associated gene, MTA1: possible interaction with histone deacetylase 1. J Exp Clin Cancer Res 19: 105-111, 2000.
35. Kumar R, Wang RA and Bagheri-Yarmand R: Emerging roles of MTA family members in human cancers. Semin Oncol 30 (Suppl 16): S30-S37, 2003.
36. Manavathi B, Peng S, Rayala SK, et al: Repression of Six3 by a corepressor regulates rhodopsin expression. Proc Natl Acad Sci USA 104: 13128-13133, 2007.
37. Toh Y and Nicolson GL: The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications. Clin Exp Metastasis 26: 215-227, 2009.
38. Luo J, Su F, Chen D, Shiloh A and Gu W: Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408: 377-381, 2000.
39. Li DQ, Ohshiro K, Reddy SD, et al: E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1. Proc Natl Acad Sci USA 106: 17493-17498, 2009.
40. Miyatani T, Kurita N, Mikami C, et al: Malignant potential of Barrett's esophagus: special reference to HDAC-1 and MTA-1 expression. Hepatogastroenterology 58: 472-476, 2011.
41. Yoo YG, Na TY, Seo HW, et al: Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene 27: 3405-3413, 2008.
42. Hofer MD, Kuefer R, Varambally S, et al: The role of metastasis-associated protein 1 in prostate cancer progression. Cancer Res 64: 825-829, 2004.
43. Taddei A, Roche D, Bickmore WA and Almouzni G: The effects of histone deacetylase inhibitors on heterochromatin: implications for anticancer therapy? EMBO Rep 6: 520-524, 2005.